Literature DB >> 21590734

Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.

Borzo Gharibi1, Anju A Abraham, Jack Ham, Bronwen A J Evans.   

Abstract

Osteoblasts and adipocytes differentiate from a common precursor cell, the mesenchymal stem cell (MSC). Adenosine is known to signal via four adenosine receptor subtypes, and significantly, recent findings indicate that these may play a role in MSC differentiation. We therefore investigated adenosine receptor expression and activation during the differentiation of MSCs to osteoblasts and adipocytes. The A(2B) R was dominant in MSCs, and its expression and activity were transiently upregulated at early stages of osteoblastic differentiation. Both activation and overexpression of A(2B) R induced the expression of osteoblast-related genes [Runx2 and alkaline phosphatase (ALP)], as well as ALP activity, and stimulation increased osteoblast mineralization. The expression of A(2A) R was upregulated during later stages of osteoblastic differentiation, when its activation stimulated ALP activity. Differentiation of MSCs to adipocytes was accompanied by significant increases in A(1) R and A(2A) R expression, and their activation was associated with increased adipogenesis. Enhanced A(2A) R expression was sufficient to promote expression of adipocyte-related genes (PPARγ and C/EBPα), and its activation resulted in increased adipocytic differentiation and lipid accumulation. In contrast, the A(1) R was involved mainly in lipogenic activity of adipocytes rather than in their differentiation. These results show that adenosine receptors are differentially expressed and involved in lineage-specific differentiation of MSCs. We conclude, therefore, that fruitful strategies for treating diseases associated with an imbalance in the differentiation and function of these lineages should include targeting adenosine receptor signal pathways. Specifically, these research avenues will be useful in preventing or treating conditions with insufficient bone or excessive adipocyte formation.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21590734     DOI: 10.1002/jbmr.424

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  63 in total

1.  A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.

Authors:  Shannon H Carroll; Nathan A Wigner; Nitin Kulkarni; Hillary Johnston-Cox; Louis C Gerstenfeld; Katya Ravid
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

2.  Adenosine A2A receptor activation prevents wear particle-induced osteolysis.

Authors:  Aránzazu Mediero; Sally R Frenkel; Tuere Wilder; Wenjie He; Amitabha Mazumder; Bruce N Cronstein
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

3.  Does adenosine play a role in bone formation, resorption and repair?

Authors:  Bronwen A J Evans
Journal:  Purinergic Signal       Date:  2012-06       Impact factor: 3.765

Review 4.  Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.

Authors:  Samaneh Arab; Akram Alizadeh; Samira Asgharzade
Journal:  Clin Exp Med       Date:  2021-01-23       Impact factor: 3.984

5.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

6.  Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation.

Authors:  Sergey Ryzhov; Bong Hwan Sung; Qinkun Zhang; Alissa Weaver; Richard J Gumina; Italo Biaggioni; Igor Feoktistov
Journal:  Purinergic Signal       Date:  2014-03-01       Impact factor: 3.765

7.  Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.

Authors:  Aránzazu Mediero; Tuere Wilder; Lopa Shah; Bruce N Cronstein
Journal:  FASEB J       Date:  2018-02-02       Impact factor: 5.191

Review 8.  Pulsed electromagnetic fields: promising treatment for osteoporosis.

Authors:  T Wang; L Yang; J Jiang; Y Liu; Z Fan; C Zhong; C He
Journal:  Osteoporos Int       Date:  2019-01-02       Impact factor: 4.507

Review 9.  The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

Review 10.  Adenosine and bone metabolism.

Authors:  Aránzazu Mediero; Bruce N Cronstein
Journal:  Trends Endocrinol Metab       Date:  2013-03-14       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.